DUO-PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DUO-PHARMA
Largest movements
- Intangible fixed assets -€33,000
down €33,000 (-80.0%), from €41,250 to €8,250
- Tangible fixed assets -€21,873
down €21,873 (-10.5%), from €207,569 to €185,696
of which Land and buildings: -€19,853
- Cash +€15,429
up €15,429 (+17.8%), from €86,817 to €102,246
mainly Other debts (+€129,567) and Depreciation (+€54,873)
- Receivables within one year +€11,955
up €11,955 (+26.5%), from €45,030 to €56,984
of which Trade receivables: +€9,954
- Other debts +€129,567
up €129,567 (+345.8%), from €37,464 to €167,031
- Profit (loss) carried forward -€129,360
down €129,360 (-82.1%), from €157,542 to €28,181
- Debts after one year -€38,563
down €38,563 (-26.9%), from €143,530 to €104,967
- Current portion of long-term debt -€24,976
down €24,976 (-36.3%), from €68,860 to €43,885
- Tax, wage and social debts +€22,571
up €22,571 (+267.5%), from €8,438 to €31,009
of which Taxes: +€22,360
- Gross operating margin +€1,908
up €1,908 (+1.3%), from €143,471 to €145,378
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €506,028 | €479,265 | -€26,763 | -5.3% |
| Fixed assets | 21/28 | €248,819 | €193,946 | -€54,873 | -22.1% |
| Intangible fixed assets | 21 | €41,250 | €8,250 | -€33,000 | -80.0% |
| Tangible fixed assets | 22/27 | €207,569 | €185,696 | -€21,873 | -10.5% |
| Land and buildings | 22 | €197,137 | €177,284 | -€19,853 | -10.1% |
| Plant, machinery and equipment | 23 | €8,513 | €7,626 | -€887 | -10.4% |
| Furniture and vehicles | 24 | €1,919 | €787 | -€1,133 | -59.0% |
| Current assets | 29/58 | €257,210 | €285,319 | +€28,110 | +10.9% |
| Stocks and contracts in progress | 3 | €122,870 | €123,737 | +€867 | +0.7% |
| Stocks | 30/36 | €122,870 | €123,737 | +€867 | +0.7% |
| Amounts receivable within one year | 40/41 | €45,030 | €56,984 | +€11,955 | +26.5% |
| Trade receivables | 40 | €41,492 | €51,445 | +€9,954 | +24.0% |
| Other amounts receivable | 41 | €3,538 | €5,539 | +€2,001 | +56.6% |
| Cash at bank and in hand | 54/58 | €86,817 | €102,246 | +€15,429 | +17.8% |
| Deferred charges and accrued income | 490/1 | €2,493 | €2,352 | -€141 | -5.7% |
| Total equity and liabilities | 10/49 | €506,028 | €479,265 | -€26,763 | -5.3% |
| Equity | 10/15 | €190,542 | €61,181 | -€129,360 | -67.9% |
| Contributions | 10/11 | €33,000 | €33,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €157,542 | €28,181 | -€129,360 | -82.1% |
| Amounts payable | 17/49 | €315,487 | €418,084 | +€102,597 | +32.5% |
| Amounts payable after more than one year | 17 | €143,530 | €104,967 | -€38,563 | -26.9% |
| Financial debts | 170/4 | €143,530 | €104,967 | -€38,563 | -26.9% |
| Amounts payable within one year | 42/48 | €170,918 | €312,128 | +€141,210 | +82.6% |
| Current portion of amounts payable after more than one year | 42 | €68,860 | €43,885 | -€24,976 | -36.3% |
| Trade debts | 44 | €56,156 | €70,204 | +€14,048 | +25.0% |
| Suppliers | 440/4 | €56,156 | €70,204 | +€14,048 | +25.0% |
| Taxes, remuneration and social security | 45 | €8,438 | €31,009 | +€22,571 | +267.5% |
| Taxes | 450/3 | €1,271 | €23,631 | +€22,360 | +1759.2% |
| Remuneration and social security | 454/9 | €7,167 | €7,377 | +€210 | +2.9% |
| Other amounts payable | 47/48 | €37,464 | €167,031 | +€129,567 | +345.8% |
| Accrued charges and deferred income | 492/3 | €1,039 | €988 | -€50 | -4.8% |
| Remuneration, social security and pensions | 62 | €46,641 | €48,022 | +€1,381 | +3.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €54,132 | €54,873 | +€741 | +1.4% |
| Other operating charges | 640/8 | €1,720 | €1,771 | +€51 | +3.0% |
| Gross operating margin | 9900 | €143,471 | €145,378 | +€1,908 | +1.3% |
| Operating profit (loss) | 9901 | €40,978 | €40,713 | -€265 | -0.6% |
| Financial income | 75/76B | €7 | €0 | -€7 | -99.6% |
| Recurring financial income | 75 | €7 | €0 | -€7 | -99.6% |
| Financial charges | 65/66B | €4,302 | €3,676 | -€626 | -14.5% |
| Recurring financial charges | 65 | €4,302 | €3,676 | -€626 | -14.5% |
| Profit (loss) for the period before taxes | 9903 | €36,683 | €37,037 | +€354 | +1.0% |
| Income taxes | 67/77 | €8,466 | €8,855 | +€389 | +4.6% |
| Profit (loss) for the period | 9904 | €28,217 | €28,181 | -€35 | -0.1% |
| Profit (loss) for the period to be appropriated | 9905 | €28,217 | €28,181 | -€35 | -0.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.